• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    US Veterinary Pain Management Market

    ID: MRFR/MED/12209-HCR
    100 Pages
    Garvit Vyas
    September 2025

    US Veterinary Pain Management Market Research Report: By Product (Medication, Devices, Animal Type, Application, Distribution Channel), By Application (Joint Pain, Postoperative Pain, Cancer, Others) and By Distribution Channel (Hospitals and Clinics, Pharmacies, others) - Forecast to 2035.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Veterinary Pain Management Market Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    US Veterinary Pain Management Market Summary

    The US Veterinary Pain Management market is projected to grow significantly from 443.1 million USD in 2024 to 936.5 million USD by 2035.

    Key Market Trends & Highlights

    US Veterinary Pain Management Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 7.04 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 936.5 million USD, indicating robust growth potential.
    • In 2024, the market is valued at 443.1 million USD, reflecting the current demand for veterinary pain management solutions.
    • Growing adoption of advanced pain management therapies due to increasing awareness of animal welfare is a major market driver.

    Market Size & Forecast

    2024 Market Size 443.1 (USD Million)
    2035 Market Size 936.5 (USD Million)
    CAGR (2025-2035) 7.04%

    Major Players

    Merial, Nestlé Purina Petcare, Vetoquinol, Veterinary Hospital Association, Aratana Therapeutics, Virbac, Neogen Corporation, Zoetis, Elanco Animal Health, Boehringer Ingelheim, PetIQ, Boehringer Ingelheim Vetmedica, Dechra Pharmaceuticals, Ceva Santé Animale, MediVet Biologics

    US Veterinary Pain Management Market Trends

    The US Veterinary Pain Management Market is experiencing significant trends driven by an increasing awareness of animal welfare and the growing demand for effective pain management solutions for pets. Pet owners are becoming more educated about the importance of managing pain in their animals, leading to an uptick in veterinary visits and consultations regarding pain relief options.

    The rise of chronic conditions in pets, paralleling the aging pet population in the US, is prompting veterinarians to seek advanced pain management therapies. This trend reflects a broader societal shift towards prioritizing quality of life in companion animals. There are numerous opportunities to explore within this market, particularly in the development of innovative treatment options.

    As the market evolves, there is a growing emphasis on non-opioid options and alternative therapies, such as acupuncture and physical therapy, to address pain management without the risks associated with traditional medications. Veterinary professionals are also focusing on multi-modal pain management strategies, which can enhance treatment effectiveness and reduce side effects.

    Recent trends indicate a shift towards integrating technology in pain management practices. Telemedicine is becoming more prevalent, allowing pet owners to consult veterinarians remotely for pain management advice. This accessibility is crucial in the US, where many rural areas may have limited access to veterinary services.

    Moreover, the increasing focus on preventative care is informing pain management strategies, encouraging pet owners to consider proactive approaches to their pets' health. Collectively, these trends highlight a dynamic landscape in the US Veterinary Pain Management Market, underscoring a commitment to better care for animals while opening avenues for growth and innovation.

    US Veterinary Pain Management Market Drivers

    Market Segment Insights

    Veterinary Pain Management Market Product Insights

    The US Veterinary Pain Management Market is characterized by a comprehensive range of products designed to alleviate pain in animals, reflecting the growing awareness and demand for effective pain management solutions. Medication is a significant component of this market, encompassing non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and adjuvant analgesics, which are increasingly being recognized for their efficacy in managing acute and chronic pain in various animal types, including pets and livestock.

    The rise in pet ownership in the US has elevated the need for effective pain management treatments in domestic animals, highlighting the importance of this product category in safeguarding animal welfare. Additionally, devices play a vital role in providing pain relief through innovative methods such as laser therapy, nerve stimulation, and cryotherapy, enhancing treatment outcomes and promoting quicker recovery in animals.

    The application of these products extends to various settings, from veterinary clinics to at-home care, indicating a diverse approach to managing animal pain and contributing to market expansion. Furthermore, the distribution channel through which these products are made available carries substantial weight in the market dynamics.

    With the advent of e-commerce, online platforms have become increasingly prominent, allowing pet owners and veterinary professionals to easily access a wide range of pain management solutions. This transition is indicative of changing consumer behaviors and the growing trend towards convenient purchasing options, which further supports the market growth in Veterinary Pain Management.

    By segmenting insights into different animal types, it's evident that companion animals such as dogs and cats significantly drive the market demand, as pet owners prioritize their pets’ health and comfort. The focus on pain management within veterinary care reflects a broader trend in healthcare emphasizing proactive measures to enhance the quality of life for animals.

    Overall, the segmentation within the US Veterinary Pain Management Market showcases a robust framework that correlates with the rising trends in pet healthcare, innovative medical advancements, and evolving consumer preferences toward maintaining the welfare of animals. This diversification within the market emphasizes the commitment to improving the effectiveness and accessibility of veterinary pain management products, positioning the sector for substantial growth in the coming years.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Veterinary Pain Management Market Application Insights

    The Application segment of the US Veterinary Pain Management Market encompasses various critical areas, including Joint Pain, Postoperative Pain, Cancer, and Others. Joint Pain is particularly significant due to the high prevalence of arthritis in aging pets, which necessitates effective pain relief strategies to enhance mobility and quality of life.

    Postoperative Pain management is becoming increasingly vital as surgical procedures for pets rise, necessitating advanced analgesic techniques to ensure optimal recovery. Cancer management represents a growing focus within veterinary medicine as the incidence of cancer in pets climbs, demanding innovative pain management solutions to address the unique needs of these patients.

    Other applications may include chronic pain conditions and trauma-related injuries, which together contribute to a diverse array of treatment options in the market. This segmentation reflects a greater awareness and emphasis on animal welfare within the US, driven by evolving veterinary practices and an increasing demand for effective pain management solutions among pet owners.

    As the industry continues to grow, innovative therapies and formulations tailored for these applications are expected to enhance the quality of care for animals, indicating a significant opportunity within the US Veterinary Pain Management Market.

    Veterinary Pain Management Market Distribution Channel Insights

    The Distribution Channel within the US Veterinary Pain Management Market plays a crucial role in delivering essential products and services to veterinary professionals and pet owners. As the market experiences significant growth, various channels are becoming increasingly important, notably Hospitals and Clinics, which serve as primary points for pain management treatments and consultations.

    The accessibility of advanced veterinary services in these establishments enhances patient care, forming a critical component of the distribution system. Pharmacies also hold a vital position, enabling convenience for pet owners seeking pain relief medications for their animals, thus widening the reach of essential products.

    Other channels further diversify the market's accessibility, providing alternatives that cater to different consumer preferences. The US Veterinary Pain Management Market statistics show that evolving trends, such as the growing awareness of animal welfare and advancements in veterinary care, are driving the demand for these distribution channels.

    However, challenges such as regulatory compliance and competition among providers remain a consideration for stakeholders. Overall, the robust network of distribution channels facilitates the effective delivery of veterinary pain management solutions, fostering continued market growth and innovation.

    Get more detailed insights about US Veterinary Pain Management Market

    Request Free Sample

    Regional Insights

    Key Players and Competitive Insights

    The US Veterinary Pain Management Market is characterized by a dynamic landscape shaped by various players focused on improving the well-being of animals experiencing pain due to surgical procedures, injuries, or chronic health issues. Key competitive insights reveal that companies are increasingly directing their resources towards the research and development of innovative pain management solutions, with a significant emphasis on both pharmaceutical products and therapeutic modalities.

    The high competition in this market drives manufacturers to achieve advancements in product efficacy, safety, and the overall convenience of administration. Additionally, the growing awareness about animal welfare and the rise in pet ownership have catalyzed demand for effective pain management solutions, prompting companies to enhance their market presence through strategic initiatives.

    Merial has established a robust presence in the US Veterinary Pain Management Market, leveraging its breadth of experience and a strong portfolio of products. The company's strengths include its commitment to research and development, which has led to the formulation of effective pain relief options tailored specifically for different species and pain types.

    Merial focuses on staying at the forefront of veterinary medicine by investing heavily in clinical studies and veterinary partnerships that inform product development and ensure that their offerings meet the real-world needs of practitioners and pet owners alike. By leveraging its established brand and robust distribution networks, Merial has managed to secure a significant market share and foster strong relationships with veterinary practitioners looking for reliable pain management solutions.

    Nestlé Purina Petcare holds a notable position in the US Veterinary Pain Management Market, offering a wide array of products and services that cater to the pain management needs of animals. The company’s focus is on integrating nutrition with pain management, providing specialized dietary solutions designed to complement veterinary treatments.

    Through strategic mergers and acquisitions, Nestlé Purina has enhanced its capabilities and expanded its market portfolio, enabling it to maintain a competitive edge. Among its key offerings are nutraceuticals that aim to alleviate pain, thereby aligning with the growing trend of holistic care in veterinary practices. The company benefits from a strong brand reputation in the pet food and care industry, which supports its efforts to cement its position in the veterinary pain management sector.

    Nestlé Purina’s strategic partnerships with veterinarians and animal health professionals further solidify its strength in delivering effective pain management solutions tailored specifically for the US market.

    Key Companies in the US Veterinary Pain Management Market market include

    Industry Developments

    The US Veterinary Pain Management Market has recently witnessed a surge in developments, with a significant focus on advancements in pain relief solutions for pets. In September 2023, Zoetis announced the launch of a new pain management solution that enhances postoperative recovery in canines, showcasing the growing emphasis on innovative therapeutic alternatives.

    Additionally, in August 2023, Merial expanded its product line aimed at treating chronic pain in older pets, which indicates an active response to an aging pet population. There have also been noteworthy mergers, such as the acquisition of Aratana Therapeutics by Elanco Animal Health in July 2023, reflecting a strategic move to consolidate resources within the pain management segment.

    Similar activity was observed when Virbac revealed plans to acquire a smaller biotech firm to enhance its research capabilities in pain management solutions in June 2023. The US market is also experiencing a steady growth trajectory, highlighted by increasing investments in Research and Development from companies such as Dechra Pharmaceuticals and Ceva Santé Animale, reinforcing their commitment to addressing veterinary pain management challenges.

    This reflects a broader trend towards better therapeutic options and care for pets, driven by evolving consumer demands and industry innovation.

    Market Segmentation

    Veterinary Pain Management Market Product Outlook

    • Medication
    • Devices
    • Animal Type
    • Application
    • Distribution Channel

    Veterinary Pain Management Market Application Outlook

    • Joint Pain
    • Postoperative Pain
    • Cancer
    • Others

    Veterinary Pain Management Market Distribution Channel Outlook

    • Hospitals and Clinics
    • Pharmacies
    • others

    Report Scope

    Report Scope:
    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 14.99(USD Billion)
    MARKET SIZE 2024 16.25(USD Billion)
    MARKET SIZE 2035 30.12(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 5.77% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED AstraZeneca, Merck, Eli Lilly, GlaxoSmithKline, BristolMyers Squibb, Gilead Sciences, Horizon Therapeutics, Purdue Pharma, Mallinckrodt, Pfizer, Amgen, AbbVie, Sanofi, Johnson and Johnson, Teva Pharmaceuticals
    SEGMENTS COVERED Types, Indication, Mode of Purchase, End-User
    KEY MARKET OPPORTUNITIES Telehealth for pain management, Innovative drug therapies, Non-opioid pain relief solutions, Personalized pain treatment plans, Advanced physiotherapy technologies
    KEY MARKET DYNAMICS Rising prevalence of chronic pain, Increasing opioid regulations, Growth of alternative therapies, Technological advancements in treatments, Aging population needing pain care
    COUNTRIES COVERED US

    Market Highlights

    Author
    Garvit Vyas
    Analyst

    Explore the profile of Garvit Vyas, one of our esteemed authors at Market Research Future, and access their expert research contributions in the field of market research and industry analysis

    Get In Touch
    Leave a Comment

    FAQs

    What is the expected market size of the US Veterinary Pain Management Market in 2024?

    The US Veterinary Pain Management Market is expected to be valued at 443.1 million USD in 2024.

    What is the projected market value for the US Veterinary Pain Management Market by 2035?

    By 2035, the market is projected to reach approximately 936.46 million USD.

    What is the expected compound annual growth rate (CAGR) for the US Veterinary Pain Management Market from 2025 to 2035?

    The expected CAGR for the market during this period is 7.04 percent.

    Which product segment is forecasted to have the highest market value in 2035?

    Medication is forecasted to have the highest market value, reaching 325.0 million USD by 2035.

    What market value is attributed to devices in the US Veterinary Pain Management Market in 2024?

    In 2024, the devices segment is valued at approximately 110.0 million USD.

    What are the expected market sizes for animal type and application segments in 2035?

    The animal type segment is expected to reach about 190.0 million USD and the application segment about 150.0 million USD by 2035.

    Which distribution channel is forecasted to decline in market value by 2035?

    The distribution channel segment is expected to decline to approximately 21.46 million USD by 2035.

    Who are the major players in the US Veterinary Pain Management Market?

    Key players in the market include Merial, Nestlé Purina Petcare, Zoetis, and Elanco Animal Health among others.

    What opportunities for growth exist in the US Veterinary Pain Management Market?

    The growing pet population and increasing awareness about pain management in animals are significant growth opportunities.

    How does the market landscape for veterinary pain management look in terms of competition?

    The competition is robust, with various companies vying for market share, contributing to innovation and product development.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. US Pain Management Market, BY Types (USD Billion)
    45. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
    46. Anticonvulsants
    47. Sedatives
    48. Narcotics
    49. Antimigraine specialists
    50. Antidepressants
    51. Others
    52. US Pain Management Market, BY Indication (USD Billion)
    53. Delegated neuropathic torment
    54. Disease torment
    55. Facial agony and headache
    56. Musculoskeletal torment
    57. Fibromyalgia
    58. Persistent back torment
    59. Joint torment
    60. Headache
    61. Post-usable torment
    62. US Pain Management Market, BY Mode of Purchase (USD Billion)
    63. Over the counter
    64. Solution-based
    65. US Pain Management Market, BY End-User (USD Billion)
    66. Emergency clinics and facilities
    67. Drug organizations
    68. Clinical gadget organizations
    69. Examination
    70. Educational establishments
    71. Others
    72. Competitive Landscape
    73. Overview
    74. Competitive Analysis
    75. Market share Analysis
    76. Major Growth Strategy in the Pain Management Market
    77. Competitive Benchmarking
    78. Leading Players in Terms of Number of Developments in the Pain Management Market
    79. Key developments and growth strategies
    80. New Product Launch/Service Deployment
    81. Merger & Acquisitions
    82. Joint Ventures
    83. Major Players Financial Matrix
    84. Sales and Operating Income
    85. Major Players R&D Expenditure. 2023
    86. Company Profiles
    87. AstraZeneca
    88. Financial Overview
    89. Products Offered
    90. Key Developments
    91. SWOT Analysis
    92. Key Strategies
    93. Merck
    94. Financial Overview
    95. Products Offered
    96. Key Developments
    97. SWOT Analysis
    98. Key Strategies
    99. Eli Lilly
    100. Financial Overview
    101. Products Offered
    102. Key Developments
    103. SWOT Analysis
    104. Key Strategies
    105. GlaxoSmithKline
    106. Financial Overview
    107. Products Offered
    108. Key Developments
    109. SWOT Analysis
    110. Key Strategies
    111. BristolMyers Squibb
    112. Financial Overview
    113. Products Offered
    114. Key Developments
    115. SWOT Analysis
    116. Key Strategies
    117. Gilead Sciences
    118. Financial Overview
    119. Products Offered
    120. Key Developments
    121. SWOT Analysis
    122. Key Strategies
    123. Horizon Therapeutics
    124. Financial Overview
    125. Products Offered
    126. Key Developments
    127. SWOT Analysis
    128. Key Strategies
    129. Purdue Pharma
    130. Financial Overview
    131. Products Offered
    132. Key Developments
    133. SWOT Analysis
    134. Key Strategies
    135. Mallinckrodt
    136. Financial Overview
    137. Products Offered
    138. Key Developments
    139. SWOT Analysis
    140. Key Strategies
    141. Pfizer
    142. Financial Overview
    143. Products Offered
    144. Key Developments
    145. SWOT Analysis
    146. Key Strategies
    147. Amgen
    148. Financial Overview
    149. Products Offered
    150. Key Developments
    151. SWOT Analysis
    152. Key Strategies
    153. AbbVie
    154. Financial Overview
    155. Products Offered
    156. Key Developments
    157. SWOT Analysis
    158. Key Strategies
    159. Sanofi
    160. Financial Overview
    161. Products Offered
    162. Key Developments
    163. SWOT Analysis
    164. Key Strategies
    165. Johnson and Johnson
    166. Financial Overview
    167. Products Offered
    168. Key Developments
    169. SWOT Analysis
    170. Key Strategies
    171. Teva Pharmaceuticals
    172. Financial Overview
    173. Products Offered
    174. Key Developments
    175. SWOT Analysis
    176. Key Strategies
    177. References
    178. Related Reports
    179. US Pain Management Market SIZE ESTIMATES & FORECAST, BY TYPES, 2019-2035 (USD Billions)
    180. US Pain Management Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)
    181. US Pain Management Market SIZE ESTIMATES & FORECAST, BY MODE OF PURCHASE, 2019-2035 (USD Billions)
    182. US Pain Management Market SIZE ESTIMATES & FORECAST, BY END-USER, 2019-2035 (USD Billions)
    183. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    184. ACQUISITION/PARTNERSHIP
    185. MARKET SYNOPSIS
    186. US PAIN MANAGEMENT MARKET ANALYSIS BY TYPES
    187. US PAIN MANAGEMENT MARKET ANALYSIS BY INDICATION
    188. US PAIN MANAGEMENT MARKET ANALYSIS BY MODE OF PURCHASE
    189. US PAIN MANAGEMENT MARKET ANALYSIS BY END-USER
    190. KEY BUYING CRITERIA OF PAIN MANAGEMENT MARKET
    191. RESEARCH PROCESS OF MRFR
    192. DRO ANALYSIS OF PAIN MANAGEMENT MARKET
    193. DRIVERS IMPACT ANALYSIS: PAIN MANAGEMENT MARKET
    194. RESTRAINTS IMPACT ANALYSIS: PAIN MANAGEMENT MARKET
    195. SUPPLY / VALUE CHAIN: PAIN MANAGEMENT MARKET
    196. PAIN MANAGEMENT MARKET, BY TYPES, 2025 (% SHARE)
    197. PAIN MANAGEMENT MARKET, BY TYPES, 2019 TO 2035 (USD Billions)
    198. PAIN MANAGEMENT MARKET, BY INDICATION, 2025 (% SHARE)
    199. PAIN MANAGEMENT MARKET, BY INDICATION, 2019 TO 2035 (USD Billions)
    200. PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2025 (% SHARE)
    201. PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2019 TO 2035 (USD Billions)
    202. PAIN MANAGEMENT MARKET, BY END-USER, 2025 (% SHARE)
    203. PAIN MANAGEMENT MARKET, BY END-USER, 2019 TO 2035 (USD Billions)
    204. BENCHMARKING OF MAJOR COMPETITORS

    US Pain Management Market Segmentation

     

     

     

    • Pain Management Market By Types (USD Billion, 2019-2035)

      • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
      • Anticonvulsants
      • Sedatives
      • Narcotics
      • Antimigraine specialists
      • Antidepressants
      • Others

     

    • Pain Management Market By Indication (USD Billion, 2019-2035)

      • Delegated neuropathic torment
      • Disease torment
      • Facial agony and headache
      • Musculoskeletal torment
      • Fibromyalgia
      • Persistent back torment
      • Joint torment
      • Headache
      • Post-usable torment

     

    • Pain Management Market By Mode of Purchase (USD Billion, 2019-2035)

      • Over the counter
      • Solution-based

     

    • Pain Management Market By End-User (USD Billion, 2019-2035)

      • Emergency clinics and facilities
      • Drug organizations
      • Clinical gadget organizations
      • Examination
      • Educational establishments
      • Others

     

     

     

     

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027